publication date: Dec. 20, 2010

In this issue: 

Troubles of two landmark cancer drugs, Celebrex and Iressa, likely to shape cancer prevention, FDA policy. FDA mulls withdrawal of Iressa.

Also in this 8-page issue: President Bush nominates EPA Administrator Michael Leavitt for HHS Secretary.

NCI selects 15 awardees to operate the Cancer Information Service.

American Legacy Foundation says group is fighting for its survival.

Funding opportunities listed.

Download (PDF 319KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.